Literature DB >> 22881205

Analysis of a tuberculosis model with a case study in Uganda.

Bruno Buonomo1, Deborah Lacitignola.   

Abstract

We consider a four-compartment tuberculosis model including exogenous reinfection. We derive sufficient conditions, in terms of the parameters of the system, which guarantee the occurrence of backward bifurcation. We also discuss the global stability of the endemic state by using a generalization of the Poincaré-Bendixson criterion. An application is given for the case of Internally Displaced People's Camps in North Uganda. The study suggests how important it is to provide qualitative indications on the threshold value of the population density in the area occupied by the camps, in order to possibly eradicate the disease.

Entities:  

Mesh:

Year:  2010        PMID: 22881205     DOI: 10.1080/17513750903518441

Source DB:  PubMed          Journal:  J Biol Dyn        ISSN: 1751-3758            Impact factor:   2.179


  5 in total

1.  A model of population dynamics of TB in a prison system and application to South Africa.

Authors:  Peter Witbooi; Sibaliwe Maku Vyambwera
Journal:  BMC Res Notes       Date:  2017-11-29

2.  Dynamic analysis of the role of innate immunity in SEIS epidemic model.

Authors:  Shikha Jain; Sachin Kumar
Journal:  Eur Phys J Plus       Date:  2021-04-23       Impact factor: 3.911

3.  Dynamics of novel COVID-19 in the presence of Co-morbidity.

Authors:  Amit Kumar Saha; Chandra Nath Podder; Ashrafi Meher Niger
Journal:  Infect Dis Model       Date:  2022-05-04

4.  Mathematical analysis and optimal control interventions for sex structured syphilis model with three stages of infection and loss of immunity.

Authors:  Abdulfatai Atte Momoh; Yusuf Bala; Dekera Jacob Washachi; Dione Déthié
Journal:  Adv Differ Equ       Date:  2021-06-11

5.  Global stability for an HIV-1 infection model including an eclipse stage of infected cells.

Authors:  Bruno Buonomo; Cruz Vargas-De-León
Journal:  J Math Anal Appl       Date:  2011-07-12       Impact factor: 1.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.